Qardio is thrilled to announce two new appointments to its C-Suite – Dr. Asif Ali, MD, as Chief Medical Officer (CMO) and Daniel Gasparini as Chief Commercial Officer (CCO). Both leaders have officially joined the team as of January 1st, 2023, bringing a wealth of experience and expertise to the company.
Dr. Asif Ali is a highly regarded cardiovascular and preventive medicine specialist with an extensive internal and cardiovascular medicine background. He currently serves on the board of the American Heart Association and holds multiple positions, including Chief Medical Officer, Chief of Education, and Chief of Cardiology, in Houston area hospitals. In addition to his medical practice, Dr. Ali is a dedicated teacher and practitioner of a wide range of cardiovascular and preventive medicine services. His expertise and valuable contributions have earned him recognition as a leading thought leader in the digital health industry.
Daniel Gasparini is a highly accomplished med-tech business executive with extensive experience with virtual care technologies and services. He has implemented remote patient care services at hundreds of independent physician practices, health systems, and medical groups.
Qardio CEO Mike Alvarez states, “We are excited to have Dr. Ali and Mr. Gasparini join the Qardio family. They will strengthen Qardio’s ability to develop and implement market-leading remote care solutions that help health care professionals improve care for patients outside of the clinical setting.“